Increased neointimal thickening in dystrophin-deficient mdx mice

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Rauch, Uwe ^a   Shami, Annelie ^a   Zhang, Feng ^a   Carmignac, Virginie ^a   Durbeej, Madeleine ^a   Hultgårdh Nilsson, Anna ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SARCOGLYCAN; DYSTROGLYCAN; DYSTROPHIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTERY LESION; ARTICLE; CAROTID ARTERY; CELL COUNT; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; BLOOD VESSEL INJURY; C57BL MOUSE; CELL CULTURE; GENETICS; METABOLISM; NEOINTIMA; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

MUS;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DYSTROPHIN; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SMOOTH, VASCULAR; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; ORGAN SIZE; UP-REGULATION; VASCULAR SYSTEM INJURIES;

EID: 84855388573     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029904     Document Type: Article

References (41)

1. Hoffman EP, Brown RJ Jr, Kunkel LM, (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
2. Engel AG, Ozawa E, (2004) Dystrophinopathies. Myology. In: Engel AG, Franzini-Armstrong C, editors. 2004 New York McGraw-Hill: 961-1025.
3. Willmann R, Possekel S, Dubach-Powell J, Meier T, Rüegg MA, (2009) Mammalian animal models for Duchenne muscular dystrophy. Neuromuscul Disord 19: 241-249.
4. Campbell KP, Kahl SD, (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338: 259-262.
5. Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP, (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315-319.
6. Yoshida M, Ozawa E, (1990) Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 108: 748-752.
7. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, et al. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702.
8. Ervasti JM, Campbell KP, (1993) A role for dystrophin associated glycoproteins as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-824.
9. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL, (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714.
10. Houzelstein D, Lyons GE, Chamberlain J, Buckingham ME, (1992) Localization of dystrophin gene transcripts during mouse embryogenesis. J Cell Biol 119: 811-821.
11. Harricane MC, Fabbrizio E, Lees D, Prades C, Travo P, et al. (1994) Dystrophin does not influence regular cytoskeletal architecture but is required for contractile performance in smooth muscle aortic cells. Cell Biol Int 18: 947-958.
12. Loufrani L, Matrougui K, Gorny D, Duriez M, Blanc I, et al. (2001) Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation 103: 864-870.
13. Straub V, Ettinger AJ, Durbeej M, Venzke DP, Cutshall S, et al. (1999) ε-sarcoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex. J Biol Chem 274: 27989-27996.
14. Barresi R, Moore SA, Stolle CA, Mendell JR, Campbell KP, (2000) Expression of γ-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. J Biol Chem 275: 38554-38560.
15. Ramirez-Sánchez I, Rosas-Vargas H, Ceballos-Reyes G, Salamanca F, Coral-Vázquez RM, (2005) Expression analysis of the SG-SSPN complex in smooth and endothelial cells of human umbilical cord vessels. J Vasc Res 42: 1-7.
16. Ito K, Kimura S, Ozasa S, Matsukura M, Ikezawa M, et al. (2006) Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum Mol Genet 15: 2266-2275.
17. Dye WW, Gleason RL, Wilson E, Humphrey JD, (2007) Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy. J Appl Physiol 103: 664-672.
18. Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, et al. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98: 465-474.
19. Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, et al. (2000) Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol Cell 5: 141-151.
20. Wheeler MT, Allikian MJ, Heydemann A, Hadhazy M, Zarnegar S, et al. (2004) Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocte degeneration in sarcoglycan-deficient cardiomyopathy. J Clin Invest 113: 668-675.
21. Yoshida T, Owens GK, (2005) Molecular determinants of vascular smooth muscle cell diversity. Circ Res 96: 280-291.
22. Rzucidlo EM, Martin KA, Powell RJ, (2007) Regulation of vascular smooth muscle cell differentiation. J Vasc Surg 45: 25A-32A.
23. Fritz KE, Jarmolych J, Daoud AS, (1970) Association of DNA synthesis and apparent dedifferentiation of aortic smooth muscle cells in vitro. Exp Mol Pathol 12: 354-362.
24. Thyberg J, (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169: 183-265.
25. Kokubo T, Uchida H, Choi ET, (2007) Integrin αvβ3 as a target in the prevention of neointimal hyperplasia. J Vasc Surg 45: SupplA; A33-8.
26. Ström Å, Wigren M, Hultgårdh-Nilsson A, Saxena A, Gomez MF, et al. (2007) Involvement of the CD1d natural killer T cell pathway in neointima fotmation after vascular injury. Circ Res 101: e83-e89.
27. Ström Å, Nordin Fredriksson G, Schiopu A, Ljungcrantz I, Söderberg I, et al. (2007) Inhibition of injury-induced arterial remodeling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. Atherosclerosis 190: 298-305.
28. Schuler F, Sorokin L, (1995) Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J Cell Sci 108: 3795-3805.
29. Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M, (2004) Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice. Hum Mol Genet 13: 1775-1784.
30. Inoue T, Node K, (2009) Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 73: 615-621.
31. Ström Å, Wigren M, Hultgårdh-Nilsson A, Saxena A, Gomez MF, et al. (2007) Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury. Circ Res 101: e83-e89.
32. Pöling J, Szibor M, Schimanski S, Ingelmann M-E, Rees W, et al. (2011) Induction of smooth muscle cell migration during arteriogenesis is mediated by Rap2. Arterioscler Thromb Vasc Biol 31: 2297-2305.
33. Hou R, Liu L, Anees S, Hiroyasu S, Sibinga NES, (2006) The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals. J Cell Biol 173: 417-429.
34. Zahradka P, Wright B, Fuerst M, Yurkova N, Molnar K, et al. (2006) Peroxisome proliferator-activated receptor α and γ ligands differentially affect smooth muscle cell proliferation and migration. J Pharmacology & Exp Therapeutics 317: 651-659.
35. Gawlik K, Durbeej M, (2011) Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skeletal Muscle 1: 9.
36. Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, et al. (2002) Disruption of Dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110: 639-648.
37. Dingemans KP, Teeling P, Lagendijk JH, Becker AE, (2000) Extracellular matrix of the human aortic media: an ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Rec 258: 1-14.
38. Rauch U, Saxena A, Lorokowski S, Rauterberg J, Björkbacka H, et al. (2011) Laminin isoforms in atherosclerotic arteries from mice and man. Histol Histopathol 26: 711-724.
39. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R, (2010) Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30: 1282-1292.
40. Tran PK, Tran-Lundmark K, Soininen R, Tryggvason K, Thyberg J, et al. (2004) Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparin sulfate-deficient perlecan. Circ Res 94: 550-558.
41. Quignard JF, Harricane MC, Ménard C, Lory P, Nargeot J, et al. (2001) Transient down-regulation of L-type Ca2+ channel and dystrophin expression after balloon injury in rat aortic cells. Cardiovasc Res 49: 177-188.